Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Insulin Lispro Low Mixture With Insulin Glargine When Initiating and Intensifying Insulin Therapy As Required in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Oral Antihyperglycemic Medication

NCT00548808 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00548808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00548808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Insulin Lispro Low Mixture With Insulin Glargine When Initiating and Intensifying Insulin Therapy As Required in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Oral Antihyperglycemic Medication
Lead sponsor
Eli Lilly and Company
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2007
Completion date
August 31, 2009
Enrollment
426 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus